6543.TWO Perfect Medical Industry Co., Ltd.
- Market cap
- TWD 1.06B
- P/E
- 28.8x
- P/B
- 1.27x
- ROE
- 6.6%
- Dividend yield
- 4.32%
- Fundamental score
- -
Ratios use the latest price and the fiscal year ending Dec 2025.
Is 6543.TWO undervalued?
Graham number6543.TWO trades 27.7% above its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Perfect Medical Industry Co., Ltd. fundamental analysis
No fundamental analysis for Perfect Medical Industry Co., Ltd. yet.
Perfect Medical Industry Co., Ltd. stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Perfect Medical Industry Co., Ltd.
Perfect Medical Industry Co., Ltd., together with its subsidiaries, engages in the manufacturing, processing, and trading of medical devices in Taiwan, Singapore, Malaysia, the United States, Vietnam, and internationally. The company offers hemodialysis blood tubing set; A.V. fistula needle set, needleless huber needle set/huber needle set; needleless transfusion set/transfusion set; needleless extension set; disposable syringe; and IV lock. It is also involved in wholesale …
Full company profilePerfect Medical Industry Co., Ltd. financial statements
Perfect Medical Industry Co., Ltd. annual financial statements (TWD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Income Statement | |||||||
| Revenue | 676M | 808M | 725M | 677M | 734M | 744M | 779M |
| Gross Profit | 153M | 253M | 210M | 134M | 201M | 238M | 201M |
| Operating Income | 50.4M | 130M | 58.5M | 3.65M | 58.4M | 91.3M | 51.3M |
| EBITDA | 82.1M | 176M | 114M | 78.2M | 115M | 167M | 146M |
| Net Income | 36.4M | 101M | 38.8M | 14.3M | 40.1M | 89.1M | 54.2M |
| EPS | 0.88 | 2.34 | 0.94 | 0.32 | 0.85 | 1.74 | 0.93 |
| Balance Sheet | |||||||
| Total Assets | 679M | 939M | 1.04B | 957M | 988M | 1.11B | 1.34B |
| Total Liabilities | 10.5M | 360M | 458M | 307M | 325M | 311M | 521M |
| Shareholders' Equity | 517M | 580M | 578M | 650M | 664M | 804M | 823M |
| Cash & Short-term Investments | 7.76M | 143M | 119M | 92.7M | 180M | 239M | 265M |
| Total Debt | 62.0M | 204M | 320M | 208M | 212M | 185M | - |
| Cash Flow | |||||||
| Operating Cash Flow | 96.0M | 118M | 4.44M | 106M | 150M | 144M | 108M |
| Capital Expenditure | 49.2M | 144M | 104M | 52.7M | 66.3M | 99.2M | 199M |
| Free Cash Flow | 46.8M | -26.3M | -99.1M | 52.9M | 83.6M | 44.3M | -91.3M |
| Ratios | |||||||
| ROE | 7.0% | 17.4% | 6.7% | 2.2% | 6.0% | 11.1% | 6.6% |
| ROA | 5.4% | 10.7% | 3.7% | 1.5% | 4.1% | 8.0% | 4.0% |
| Net Profit Margin | 5.4% | 12.5% | 5.4% | 2.1% | 5.5% | 12.0% | 7.0% |
| Debt to Equity | 0.12x | 0.35x | 0.55x | 0.32x | 0.32x | 0.23x | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Perfect Medical Industry Co., Ltd. dividends
- Dividend yield
- 4.32%
- Forward dividend
- 0.34 TWD
- Payout ratio
- 84.5%
- Ex-dividend date
- Sep 2, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | TWD 45.8M | 0.79 | 84.5% |
| 2024 | TWD 65.1M | 1.27 | 73.1% |
| 2023 | TWD 16.9M | 0.36 | 42.1% |
| 2022 | TWD 14.4M | 0.32 | 101.1% |
| 2021 | TWD 58.8M | 1.42 | 151.6% |
| 2020 | 27.4M | 0.64 | 27.2% |
| 2019 | 27.4M | 0.67 | 75.3% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 1027.09:1000 on Aug 13, 2026.
Who owns Perfect Medical Industry Co., Ltd.
Ownership data of Perfect Medical Industry Co., Ltd. is not available yet.
Perfect Medical Industry Co., Ltd. company profile
- Company name
- Perfect Medical Industry Co., Ltd.
- Ticker
- 6543.TWO
- ISIN
- TW0006543002
- Exchange
- Taiwan OTC Exchange
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Fiscal year end
- December
- Address
- No.100, Xingong 1st Road, Changhua, Taiwan, 521051
- Phone
- 886 4 8887 998
- Website
- perfectmedical.com.tw
About Perfect Medical Industry Co., Ltd.
Perfect Medical Industry Co., Ltd., together with its subsidiaries, engages in the manufacturing, processing, and trading of medical devices in Taiwan, Singapore, Malaysia, the United States, Vietnam, and internationally. The company offers hemodialysis blood tubing set; A.V. fistula needle set, needleless huber needle set/huber needle set; needleless transfusion set/transfusion set; needleless extension set; disposable syringe; and IV lock. It is also involved in wholesale and retail trading of medical consumables. The company was founded in 1989 and is headquartered in Changhua, Taiwan.
Perfect Medical Industry Co., Ltd. management
5- Mr. Kuo-Chi HsuRepresentative Chairman & CEO
- Ms. Ya-Tung YeCFO & Accounting Supervisor
- Mr. Tung-Shun ChenAssistant Manager of Legal and Regulation Department and Quality Assurance Department
- Mr. Shun-Jie XuDeputy General Manager of Management & Sustainable Operations
- Mr. Hung-Jen ChenGeneral Manager